MedPath

Better postoperative pain management with epidural dexmedetomidine versus buprenorphine

Phase 4
Conditions
Health Condition 1: null- ASA physicalstatus I &II posted for elective lower abdominal surgeries
Registration Number
CTRI/2018/02/011977
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients of ASA physical status I-II

2.Aged between 18 to 65 years of either sex.

Exclusion Criteria

1.Contraindications to regional anesthesia:

2.Raised ICT

3.Patients refusal

4.local site infection

5.coagulation abnormalities,

6.allergy to local anaesthetics (amide group),

7.previous spine surgeries / spine deformities

8.Morbidly obese patients

9.neurologic, psychiatric disease, severe renal or hepatic derangement

10.Patients with history of drug abuse.

11.History of allergy or contraindications to either Dexmedetomidine or buprenorphine .

12.Concomitant use of medications which may exaggerate the heart rate response of Dexmedetomidine including digoxin or β-adrenergic antagonists.

ï?¶Patients who are pregnant and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
analgesic effectivenessTimepoint: analgesic effectiveness
Secondary Outcome Measures
NameTimeMethod
sedation,nausea, vomiting, pruritis, other side effects and hemodynamicsTimepoint: heart rate, blood pressure and respiratory rate recorded every 5min for first 30 min, every 10min for next 30min, every 15min next 60min and at every 30mins for next 4 hours.
© Copyright 2025. All Rights Reserved by MedPath